Drug
Dapansutrile
Dapansutrile is a pharmaceutical drug with 6 clinical trials. Currently 4 active trials ongoing.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
4(67%)
Terminated
1(17%)
Phase Distribution
Ph early_phase_1
1
17%
Ph phase_1
1
17%
Ph phase_2
4
67%
Phase Distribution
2
Early Stage
4
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
4(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
4
trials recruiting
Total Trials
6
all time
Status Distribution
Active(5)
Terminated(1)
Detailed Status
Recruiting3
Active, not recruiting1
Terminated1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
4
Success Rate
0.0%
Most Advanced
Phase 2
Trials by Phase
Early Phase 11 (16.7%)
Phase 11 (16.7%)
Phase 24 (66.7%)
Trials by Status
recruiting350%
active_not_recruiting117%
terminated117%
not_yet_recruiting117%
Recent Activity
4 active trials
Showing 5 of 6
recruitingphase_2
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
NCT05658575
recruitingphase_2
A Trial to Test the Use of Dapansutrile, an Anti-inflammatory Medication, in People With Parkinson's Disease
NCT07157735
recruitingphase_2
Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia
NCT06047262
active_not_recruitingphase_1
A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma
NCT04971499
not_yet_recruitingearly_phase_1
Multimodality Cardiovascular Imaging for the Translation of Therapies for Vascular Activation After MI
NCT05880355
Clinical Trials (6)
Showing 6 of 6 trials
NCT05658575Phase 2
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
NCT07157735Phase 2
A Trial to Test the Use of Dapansutrile, an Anti-inflammatory Medication, in People With Parkinson's Disease
NCT06047262Phase 2
Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia
NCT04971499Phase 1
A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma
NCT05880355Early Phase 1
Multimodality Cardiovascular Imaging for the Translation of Therapies for Vascular Activation After MI
NCT03595371Phase 2
Pilot Study of Dapansutrile Capsules in Schnitzler's Syndrome
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6